Skip to main content
. 2010 May 31;31(15):1845–1853. doi: 10.1093/eurheartj/ehq161

Table 1.

Baseline clinical and electrocardiography characteristics and 30-day mortality in patients with different aVR ST levels

Lead aVR
P-value
ST↑ ≥1 mm No ST ↑ ≥1 mm
Anterior AMI group (n = 7664) n = 779 n = 6885

Demographics
 Age (years) (IQR) 64 (54–72) 61 (51–70) <0.0001
 Women (%) 257 (33.0) 1928 (28.0) 0.0035

History of cardiac disease
 Angina (%) 476 (61.1) 3358 (48.8) <0.0001
 Myocardial infarction (%) 164 (21.1) 1049 (15.2) <0.0001

Risk factors
 Hypertension (%) 461 (59.2) 3580 (52.0) <0.0001
 Diabetes (%) 100 (12.8) 941 (13.7) 0.5214
 Smoking history
  Never smoked (%) 353 (45.3) 2802 (40.7) 0.0302
  Past smoker (%) 130 (16.7) 1157 (16.8)
  Current smoker (%) 296 (38.0) 2926 (42.5)

Time from symptom onset to randomization
 ≤2 h (%) 167 (21.4) 1323 (19.2) 0.0803
 >2 but ≤4 h (%) 404 (51.9) 3475 (50.5)
 >4 h (%) 208 (26.7) 2085 (30.3)

Haemodynamics
 Systolic blood pressure (IQR) (mmHg) 140 (120–150) 139 (120–150) 0.9033
 Diastolic blood pressure (IQR) (mmHg) 80 (74–90) 80 (75–90) 0.8419
 Heart rate (IQR) (b.p.m.) 82 (72–94) 80 (69–90) <0.0001

Killip class
 I (%) 540 (69.3) 5262 (76.4) <0.0001
 II (%) 185 (23.8) 1360 (19.8)
 III (%) 42 (5.4) 185 (2.7)
 IV (%) 12 (1.5) 78 (1.1)
Summed ST elevationa (IQR) (mm) 12 (8–12) 15.5 (10–23.5) <0.0001
Summed ST depressiona (IQR) (mm) 6 (3.5–8.5) 1.5 (0.5–3) <0.0001
30-day mortality 121 (15.5%) 837 (12.2%) 0.0069
 Without RBBB (n = 7299) (%) 110 (14.7) 735 (11.2) 0.0045
 With RBBB (n = 365) (%) 11 (34.4) 102 (30.6) 0.6617

Inferior AMI group (n = 8161) n = 365 n = 7796

Demographics
 Age (years) (IQR) 66 (57–73) 60 (51–69) <0.0001
 Women (%) 179 (49.0) 2086 (26.8) <0.0001

History of cardiac disease
 Angina (%) 243 (66.6) 3304 (42.4) <0.0001
 Myocardial infarction (%) 117 (32.1) 966 (12.8) <0.0001

Risk factors
 Hypertension (%) 250 (68.5) 3842 (49.3) <0.0001
 Diabetes (%) 81 (22.2) 1057 (13.6) <0.0001
 Smoking history
  Never smoked (%) 200 (54.8) 2723 (34.9) <0.0001
  Past smoker (%) 56 (15.3) 1366 (17.5)
  Current smoker (%) 109 (29.9) 3707 (47.6)

Time from symptom onset to randomization
 ≤2 h (%) 51 (14.0) 1777 (22.8) <0.0001
 >2 but ≤4 h (%) 187 (51.2) 3921 (50.3)
 >4 h (%) 127 (34.8) 2093 (26.9)

Haemodynamics
 Systolic blood pressure (IQR) (mmHg) 140 (120–150) 130 (120–150) 0.0010
 Diastolic blood pressure (IQR) (mmHg) 80 (70–90) 80 (70–90) 0.0605
 Heart rate (IQR) (b.p.m.) 80 (70–97) 72 (62–84) <0.0001

Killip class
 I (%) 246 (67.4) 6565 (84.2) <0.0001
 II (%) 84 (23.0) 1061 (13.6)
 III (%) 25 (6.9) 87 (1.1)
 IV (%) 10 (2.7) 83 (1.1)
Summed ST elevationa (IQR) (mm) 5 (3–7.5) 8 (5–12) <0.0001
Summed ST depressionb (IQR) (mm) 12 (7.5–17.5) 6.5 (3.5–11.5) <0.0001
30-day mortality 58 (15.9%) 509 (6.5%) <0.0001
 Without RBBB (n = 8016) (%) 58 (16.0) 492 (6.4) <0.0001
 With RBBB (n = 145) (%) 0 17 (12.0) 1.0000

aSummed ST elevation refers to ST elevation.

bSummed ST depression refers to ST depression in the other 11 ECG leads other than lead aVR.